Articles by Keyword for

According to an article published in the April 2013 issue of the journal Internal Medicine, patients on SSRI antidepressants at the time of surgery have a 20% increased mortality, 9% increased risk for bleeding, and 22% increased risk for  readmission within a month of discharge from the hospital! This was based on a review of 530,000 surgical patients from...

There are many ways to evaluate and treat impotence that range from drug therapies to nutrients and supplements or even surgery.            

  For men with localized prostate cancer, surgery does not save lives and it has a much higher rate of complications such as impotence and incontenance. However, once a man knows he has prostate cancer, he has a powerful drive to get it out even if the data does not support this approach. The word, "cancer" scares us. We need much better...

A meta-analysis of 61 studies that was published in the prestigious Public Library of Science looked at the relationship between antidepressant usage and breast and ovarian cancer. There was a statistically significant increase in risk for both these cancers in women on SSRI antidepressants. The findings remain controversial because women with breast cancer who...

  Combining SSRI antidepressants with aspirin or other NSAIDs can lead to a 42% increase risk for bleeding. SSRIs may inhibit the uptake and storage of serotonin by platelets. Low platelet serotonin leads to reduced platelet aggregation and a tendency to bleed. Considering that SSRIs have little evidence that they work better than placebo and that...

In our pharmaceutically oriented culture, antidepressants are often looked as the solution for depression. We want the quickest fix that will get us back on our feet and back to work. And the medical profession has been trained to resort to using antidepressants, especially the SSRI type that include Prosac, Zoloft, Celexa, Lexapro, Paxil, and Luvox rather than...

SSRI antidepressants, according to research published in the February issue of Neuroscience and Biobehavioral Reviews, may increase serum levels of serotonin, but actually lower levels in the brain. This family of drugs blocks the re-uptake of serotonin by nerve tissue, which raises serum levels but actually lowers levels where we need them the most -- in...